181 related articles for article (PubMed ID: 19761133)
21. Usefulness of CA125 in the differential diagnosis of uterine adenomyosis and myoma.
Kil K; Chung JE; Pak HJ; Jeung IC; Kim JH; Jo HH; Kim MR
Eur J Obstet Gynecol Reprod Biol; 2015 Feb; 185():131-5. PubMed ID: 25577553
[TBL] [Abstract][Full Text] [Related]
22. Assessment of MR Imaging as a Tool to Differentiate between the Major Histological Types of Uterine Sarcomas.
Sumi A; Terasaki H; Sanada S; Uchida M; Tomioka Y; Kamura T; Yano H; Abe T
Magn Reson Med Sci; 2015; 14(4):295-304. PubMed ID: 26104072
[TBL] [Abstract][Full Text] [Related]
23. Prognostic value of alternative lengthening of telomeres-associated biomarkers in uterine sarcoma and uterine carcinosarcoma.
Lee YK; Park NH; Lee H
Int J Gynecol Cancer; 2012 Mar; 22(3):434-41. PubMed ID: 22266933
[TBL] [Abstract][Full Text] [Related]
24. Preoperative diagnosis of atypical pelvic leiomyoma and sarcoma: the potential role of diffusion-weighted imaging.
Valdes-Devesa V; Jimenez MDM; Sanz-Rosa D; Espada Vaquero M; Alvarez Moreno E; Sainz de la Cuesta Abbad R
J Obstet Gynaecol; 2019 Jan; 39(1):98-104. PubMed ID: 30207503
[TBL] [Abstract][Full Text] [Related]
25. Analysis of uterine corporeal mesenchymal tumors occurring after menopause.
Ishidera Y; Yoshida H; Oi Y; Katayama K; Miyagi E; Hayashi H; Shigeta H
BMC Womens Health; 2019 Jan; 19(1):13. PubMed ID: 30658711
[TBL] [Abstract][Full Text] [Related]
26. Growth differentiation factor-15 as biomarker in uterine sarcomas.
Trovik J; Salvesen HB; Cuppens T; Amant F; Staff AC
Int J Gynecol Cancer; 2014 Feb; 24(2):252-9. PubMed ID: 24401984
[TBL] [Abstract][Full Text] [Related]
27. Incidence and outcome of occult uterine sarcoma: A multi-centre study of 18604 operations performed for presumed uterine leiomyoma.
Yorgancı A; Meydanlı MM; Kadıoğlu N; Taşkın S; Kayıkçıoğlu F; Altın D; Atasoy L; Haberal AN; Kınay T; Akgül MA; Tapısız ÖL; Evliyaoğlu Ö; Tekin ÖM; Fırat Ortaç U; Ayhan A
J Gynecol Obstet Hum Reprod; 2020 Jan; 49(1):101631. PubMed ID: 31499285
[No Abstract] [Full Text] [Related]
28. Investigating the diagnostic value of quantitative parameters based on T2-weighted and contrast-enhanced MRI with psoas muscle and outer myometrium as internal references for differentiating uterine sarcomas from leiomyomas at 3T MRI.
Malek M; Rahmani M; Seyyed Ebrahimi SM; Tabibian E; Alidoosti A; Rahimifar P; Akhavan S; Gandomkar Z
Cancer Imaging; 2019 Apr; 19(1):20. PubMed ID: 30935419
[TBL] [Abstract][Full Text] [Related]
29. Age-stratified risk of unexpected uterine sarcoma following surgery for presumed benign leiomyoma.
Brohl AS; Li L; Andikyan V; Običan SG; Cioffi A; Hao K; Dudley JT; Ascher-Walsh C; Kasarskis A; Maki RG
Oncologist; 2015 Apr; 20(4):433-9. PubMed ID: 25765878
[TBL] [Abstract][Full Text] [Related]
30. Prediction of Occult Uterine Sarcoma before Hysterectomy for Women with Leiomyoma or Abnormal Bleeding.
Lentz SE; Zaritsky E; Tucker LY; Lee C; Lazo IM; Niihara A; Yamamoto M; Raine-Bennett T
J Minim Invasive Gynecol; 2020; 27(4):930-937.e1. PubMed ID: 31352067
[TBL] [Abstract][Full Text] [Related]
31. The differential diagnoses of uterine leiomyomas and leiomyosarcomas using DNA and RNA sequencing.
Mas A; Alonso R; Garrido-Gómez T; Escorcia P; Montero B; Jiménez-Almazán J; Martín J; Pellicer N; Monleón J; Simón C
Am J Obstet Gynecol; 2019 Oct; 221(4):320.e1-320.e23. PubMed ID: 31121144
[TBL] [Abstract][Full Text] [Related]
32. Pathologic quiz case: a 40-year-old woman with a large pelvic mass, ascites, massive right hydrothorax, and elevated CA 125. Uterine symplastic leiomyoma associated with pseudo-Meigs syndrome and elevated CA 125.
Weinrach DM; Wang KL; Keh P; Sambasiva Rao M
Arch Pathol Lab Med; 2004 Aug; 128(8):933-4. PubMed ID: 15270600
[No Abstract] [Full Text] [Related]
33. [Diagnosis and treatment of uterine sarcoma].
Bazikian GK; Savinova VF
Akush Ginekol (Mosk); 1978 Dec; (12):27-9. PubMed ID: 736228
[No Abstract] [Full Text] [Related]
34. Circulating Protein Biomarkers to Differentiate Uterine Sarcomas from Leiomyomas.
Glorie N; Baert T; VAN DEN Bosch T; Coosemans AN
Anticancer Res; 2019 Aug; 39(8):3981-3989. PubMed ID: 31366479
[TBL] [Abstract][Full Text] [Related]
35. Liquid Biopsy as a Tool for Differentiation of Leiomyomas and Sarcomas of Corpus Uteri.
Dvorská D; Škovierová H; Braný D; Halašová E; Danková Z
Int J Mol Sci; 2019 Aug; 20(15):. PubMed ID: 31387281
[TBL] [Abstract][Full Text] [Related]
36. Incidental finding of endolymphatic stromal myosis during luteinizing hormone releasing hormone agonist therapy for suspected benign uterine myomata. A case report.
Smith S; Cooper M; Schinfeld JS
J Reprod Med; 1992 Dec; 37(12):980-2. PubMed ID: 1287209
[TBL] [Abstract][Full Text] [Related]
37. Utility of Clinical Parameters and Multiparametric MRI as Predictive Factors for Differentiating Uterine Sarcoma From Atypical Leiomyoma.
Bi Q; Xiao Z; Lv F; Liu Y; Zou C; Shen Y
Acad Radiol; 2018 Aug; 25(8):993-1002. PubMed ID: 29422425
[TBL] [Abstract][Full Text] [Related]
38. Leiomyosarcoma of the uterus.
Gudgeon DH
Obstet Gynecol; 1968 Jul; 32(1):96-100. PubMed ID: 5742096
[No Abstract] [Full Text] [Related]
39. "
Malvika S; Parikshaa G; Nalini G; Sujata S; Veenu S; Bhavana R; Rashmi B
Int J Surg Pathol; 2023 Aug; 31(5):714-720. PubMed ID: 35975574
[TBL] [Abstract][Full Text] [Related]
40. Hydropic degenerating leiomyoma presenting as pseudo-Meigs syndrome with elevated CA 125.
Dunn JS; Anderson CD; Method MW; Brost BC
Obstet Gynecol; 1998 Oct; 92(4 Pt 2):648-9. PubMed ID: 9764648
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
